Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05744960 · ClinicalTrials.gov registry record · NA
Impact of Financial Incentives
A NA study of Human Papilloma Virus, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT05744960: Active NA study of Human Papilloma Virus, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT05744960 is a NA study of Human Papilloma Virus that is active but no longer recruiting, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 34 participants, below the 8,440-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05744960, a NA study of Human Papilloma Virus, is active but no longer recruiting, sponsored by UNC Lineberger Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial will look at the impact of clinic-level financial incentives to improve provider communication and increase HPV vaccine uptake. Some clinics will receive communication training. Other clinics will receive the same training and a clinic-level financial incentive program with a monthly data feedback report to increase HPV vaccine uptake.
Primary Outcome
Proportion of unvaccinated children who initiate the HPV vaccine series between baseline and 12-month follow-up, among those who were ages 9-12 at baseline.
Conditions Studied
Interventions
- BEHAVIORAL Communication training
- BEHAVIORAL financial Incentive
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2023-02-28 |
| Est. Completion | 2026-08-29 |
| Phase | NA |
What the registry record for NCT05744960 still lists
NCT05744960 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 8,440-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Human Papilloma Virus appearing as the primary indexed condition, and to 2 interventions - of which Communication training is the first listed.
NCT05744960 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05744960 about?
NCT05744960 is a clinical study titled "Impact of Financial Incentives". This trial will look at the impact of clinic-level financial incentives to improve provider communication and increase HPV vaccine uptake. Some clinics will receive communication training. Other clinics will receive the same training and a clinic-level financial incentive program with a monthly data...
What is the current status of trial NCT05744960?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2023-02-28. Estimated completion is 2026-08-29.
What conditions does trial NCT05744960 study?
This clinical trial studies the following conditions: Human Papilloma Virus.
What interventions are being tested in trial NCT05744960?
The interventions under investigation include: Communication training (BEHAVIORAL), financial Incentive (BEHAVIORAL).
Who is sponsoring clinical trial NCT05744960?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05744960 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05744960's enrollment target sits among peer trials
34 34th of 39 higher than 6 of 39 other Human Papilloma Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Papilloma Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
RECRUITING · NA
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
RECRUITING · NA
-
Provider Recommendation and HPV Vaccination
RECRUITING · NA
-
Impact of Standing Orders Optimization
ACTIVE NOT RECRUITING · NA
-
Development of a Self-collection Device for Cervical Cancer Screening
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI